Distinguishing Batten (CLN2): Navigating the differential diagnosis and referral pathways

Jul 15, 2026 13:00
English
CLN2
Rare Diseases
CLN-S1-M2
Registration is free and a certificate of attendance will be provided by the Excellence in Pediatrics Institute. By registering, you will also have access to the webinar on demand once the session has concluded.
Register Now

This webinar addresses the challenge of distinguishing CLN2disease from common diagnostic pathways that can delay recognition, including epilepsy, behavioral disorders, and developmental concerns. Led by Prof. Pasquale Striano and  Dr Marina Trivisano the session focuses on identifying early diagnostic pitfalls, recognizing progression patterns that should prompt reassessment, and applying a structured differential diagnosis framework.Participants will gain practical insight into when CLN2 should enter the differential, how symptom clustering can shift clinical decision-making, and when urgent referral and timely genetic testing discussion are indicated.

The session examines CLN2 disease through the lens of differential diagnosis and referral pathways, focusing on the point at which a common diagnosis no longer explains the child’s clinical trajectory. The webinar combines clinical framing, diagnostic pitfall analysis, disease-specific differential diagnosis, and practical escalation guidance to support earlier recognition and referral.

Expert presentations cover:

  • Clinical framing (Dr Marina Trivisano and DrPasquale Striano): Recapping key signs and symptoms that should raise suspicion of CLN2 disease and explaining why rare diseases can be dropped from the differential once a common diagnosis is applied.
  •  Early diagnostic pitfalls (Dr Marina Trivisano): Exploring epilepsy-first pathways, seizure-focused anchoring, behavioral or developmental labelling, and the distinction between developmental delay, plateau, and true regression.
  • Differential diagnosis in practice (Dr Pasquale Striano): Examining typical misattribution pathways, red-flag symptom combinations, progression patterns, and the clinical consequences of delayed escalation.
  • Testing and escalation (Dr Marina Trivisano): Using a comparative case example to illustrate early versus delayed recognition, applying the CLN2 clinical rating scale, and translating diagnostic results into timely next steps.

The discussion features:

  • When clinicians should stop and reassess the original diagnosis
  • Balancing watchful waiting with escalation in everyday practice
  • Where delays most commonly occur across services and specialties
  • Sequential versus parallel investigations and their impact on time to diagnosis
  • Clarifying ownership of diagnostic coordination and next steps

Learning Objectives

Bythe end of this webinar, participants will be able to:

  1. Explain how common diagnostic pathways, including epilepsy, behavioral disorders, and developmental conditions, can delay recognition of CLN2 disease
  2. Apply a structured differential diagnosis framework when CLN2 disease is a consideration
  3. Identify red-flag symptom combinations and progression patterns that justify escalation beyond common diagnoses
  4. Determine when urgent referral and timely genetic testing discussion are indicated in children with suspected CLN2 disease
Register Now